Compare PROV & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROV | STXS |
|---|---|---|
| Founded | 1956 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4M | 86.4M |
| IPO Year | 2009 | 2004 |
| Metric | PROV | STXS |
|---|---|---|
| Price | $18.13 | $1.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $18.50 | $3.00 |
| AVG Volume (30 Days) | 12.9K | ★ 705.6K |
| Earning Date | 10-27-2026 | 11-10-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | 10.75 | ★ 16.67 |
| EPS | ★ 1.03 | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | $4.36 | $6.04 |
| Revenue Next Year | $0.72 | $33.01 |
| P/E Ratio | $17.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.95 | $0.80 |
| 52 Week High | $18.99 | $2.89 |
| Indicator | PROV | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 54.65 |
| Support Level | $18.04 | $0.95 |
| Resistance Level | $18.91 | $1.97 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 10.10 | 98.33 |
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.